Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Lancet 375 , 14471456 (2010)
All authors participated in the analysis and interpretation of data, critical revision of the manuscript for important intellectual content and approved the final version submitted for publication
Their identification of the amino acid sequence of the biologically active GLP-1 hormone laid the groundwork for drugs in the management of type 2 diabetes
Clinical Trial Results STEP trials (Semaglutide Treatment Effect in People with obesity): Average weight loss of ~15% of total body weight
The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: results of a pilot randomized, double-blind, placebo-controlled trial
US$ 28.55
US$ 29.85
US$ 28.94
US$ 23.36
US$ 25.40
US$ 25.62
